Pharmacy Podcast Network

Transforming Patient Engagement with LifeLink Systems

We talk with Greg Johnsen, CEO at Lifelink Systems, Inc.
#TogetheRx we are transforming patient engagement across the healthcare industry by giving hospital systems and life sciences companies advanced conversational technology to interact with patients where they spend their time — messaging on mobile devices. Our technology turns the smartphone into the next-generation healthcare worker, capable of handling complex workflows at unlimited scale.
Information technology has come a long way, but successful user engagement has proven to be a surprisingly daunting last-mile challenge. Healthcare is complicated and the digital tools offered to patients reflect that, which results in low adoption and satisfaction. Delivering digital patient experiences remains a strategic priority, but the healthcare industry needs to reimagine patient-facing technology. The challenge remains: How do we make the complex exceedingly simple, exceedingly intuitive?
It turns out that the simplest, most intuitive human interface is a conversation. It’s natural, requires no training, is infinitely flexible, self-directed, and responsive. With smartphone adoption rates approaching 90%, the opportunity to engage in conversation-based information exchanges is in the palms of everyone’s hands. Today, any human with a mobile phone can converse with complex IT systems with ease, and immediately, by relying on smart, context-aware digital assistants.
The technology for enabling conversational AI will transform consumer engagement strategies across every industry sector, but it will have an especially profound impact on process-centric customer care industries. Like Healthcare.
Conversational AI not only closes a service gap, it improves the quality of the service itself while also providing the engagement horsepower to scale up service operations profitably. Digital assistants carry the encoded protocols, orders, and best practices to the patient in the form of smart, engaging conversations.
Importantly, conversational AI technology doesn’t replace human expertise and services, it augments care teams by taking on all of the redundant, high-volume processes. Companies that are taking advantage of this powerful new technology are transforming the patient experience, and dramatically improving customer service across the board.
Learn more about your ad choices. Visit megaphone.fm/adchoices

To MME or Not to MME, Is There a Question? | PAIN POD

Let’s face it, when it comes to pain management, one of the most painful efforts of the last few years has involved, in one way, shape, form, or fashion: Morphine Milligram Equivalents (MMEs). As we discussed with the PharmD author of the 2022 CDC Opioid Guideline Update , there are no MME factor changes on the horizon, so just when will we have our minds wrapped around the concept?!?
 
Join the Mark “Pain Guy” Garofoli on the Pain Pod for a dynamic discussion on wrestling (yes, you read that right!), pain management, our healthcare system, and the “street” version of MMEs. Wait, there’s a street version of MMEs? Yes, yes there is, so tune in now to the Pain Pod as you’ll only utilize the edge of your seat even though ya paid for the whole seat!
 
Come one, come all, to the Pain Pod!!!
 
Episode Notes
 
Pre-2016 MME Charts Review
2016 CDC Chronic Pain Opioid Guideline MME Chart
·      CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017.
o   Tramadol: 0.1
o   Codeine: 0.15
o   Tapentadol: 0.4
o   Morphine: 1
o   Hydrocodone: 1
o   Oxycodone: 1.5
o   Oxymorphone: 3
o   Hydromorphone: 4
o   Methadone (Up to: 20mg, 40mg, 60mg, >60mg): 4, 8, 10, 12
o   Transdermal Fentanyl: 7.2 (Divided by the # of Days Applied)
o   Transdermal Buprenorphine: 12.6 (Divided by the # of Days Applied)
o   Buprenorphine (SL or Buccal): 0.03 (for mcg calculations) or 30 (for mg calculations)
· Nielson S. et. al. A synthesis of oral morphine equivalents (OME) for opioid utilization studies. Pharmacoepidemiology and drug safety 2016; 25: 733–737
 
 
2015 Cat and Dog MME Article
· https://burrardvet.com/2015/04/08/pain-control-in-dogs-cats
 
2016 CDC Chronic Pain Opioid Guideline MME Chart
· CDC Chronic Pain Opioid Guidelines: MMWR March 2016. Updated 2017.
 
2022 CDC Opioid Guideline Revision Resources
· https://www.federalregister.gov/documents/2022/02/10/2022-02802/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioids
 
2010 to 2014 MME Relative Risk of Overdose/Death
· https://i1.wp.com/face-facts.org/wp-content/uploads/2017/04/Opioid-dose-vs-overdose-risk.jpg
 
Missouri Marijuana Equivalents (MMEs)
· https://north.life/demystifying-missouri-medical-marijuana-equivalency-units-mmes/
 
 
Audio Add-in’s
Let’s Get Ready to Rumble (Michael Buffer)
· https://www.youtube.com/watch?v=jgopHWACUXs
 
Cash sound
· https://www.youtube.com/watch?v=ZeET7Z1ZGlw
 
Ron Burgundy “That Escalated Quickly”
· https://www.youtube.com/watch?v=FONN-0uoTHI
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Impact of a Nitric Oxide Supplement | Pharmacy Profit Summit 2022

Your ability to produce Nitric Oxide (N-O) declines rapidly as you age. Berkeley Life Professional’s proprietary dietary nitrate blend provides the plant-based bio-equivalents of a leafy green diet in each two capsule dose helping you maintain Nitric Oxide levels as you age. This interview with Berkeley Life CEO John Halbert is a terrific testimonial to the importance of the supplement and to the revenue opportunity for community pharmacies. RxSafe, RMS, and Berkeley Life will be sponsoring the 2022 Pharmacy Profit Summit in Dallas Texas hosted by DiversifyRx.
Learn more: https://www.berkeleylife.com/
Learn more about your ad choices. Visit megaphone.fm/adchoices

How Interest Rate Hikes Affect Pharmacy Owners | Live Oak Bank

In this episode, Greco DeValencia of Live Oak Bank and Owen BonDurant and Rich Danhof of Independent Rx discuss the recent rate hikes, how it affects current pharmacy owners and owners to be and what to be concerned about beyond just the headlines of rising rates.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect

Accreditation and support statement:
· PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit.
· This activity is supported by educational grant from GlaxoSmithKline.
Objectives
• Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer.
• Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer.
 
Learn more about your ad choices. Visit megaphone.fm/adchoices

HIV Preexposure Prophylaxis (PrEP): Exploring the Current and Emerging Landscape | PTCE Pharmacy Connect

 Educational Objectives
·      Discuss currently available options for pre-exposure prophylaxis (PrEP) in the prevention of HIV.
·      Describe the role of pharmacists in improving PrEP uptake in the United States. 
 
 
Faculty:
Drew W. Cates, PharmD, AAHIVP,
Educational Manager
SynerGrx
Chamblee, Georgia 
Faculty, has the following financial relationships with commercial interests to disclose:
Speaker's Bureau: Gilead
 
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.07 CEU) under the ACPE universal activity number 0290-0000-22-338-H02-P. The activity is available for CE credit through July 29, 2023.
This activity is supported by an educational grant from ViiV.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS | PTCE Pharmacy Connect

Educational Objectives
• Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC)
• Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations
 
Josiah D. Land, PharmD, BCOP
Clinical Pharmacy Specialist – Thoracic Medical Oncology
Department of Pharmacy
Memorial Sloan Kettering Cancer Center
New York, New York
 
Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose:
Consultant (advisory board): Bristol Myers Squibb
 
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023.
 
This activity is supported by educational funding provided by Amgen.
Learn more about your ad choices. Visit megaphone.fm/adchoices

”Sex Matters” with Dr Alyson McGregor | Sex PharmD

This episode interviews Dr Alyson McGregor, MD Professor of Emergency Medicine and Associate Dean of Clinical Faculty Affairs and Development at University of South Carolina School of Medicine Greenville. 
Dr McGregor is a sex and gender expert, educator and advocate. Dr McGregor discusses her book, Sex Matters: How Male-Centric Medicine Endangers Women's Health and What We Can Do About It. 
https://www.alysonmcgregormd.com/
@amcgregormd
Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing the Conversation: Optimizing Frontline Immunotherapy Outcomes in NSCLC and Managed Care Considerations | PTCE Pharmacy Connect

Educational Objectives
·      Review the efficacy and safety of emerging frontline immune checkpoint inhibitor (ICI) used as monotherapy and in combination regimens
·      Indicate the impact of ICIs and programmed death-ligand 1 testing on cost-effectiveness and patient reported outcomes related with frontline use of ICIs in advanced NSCLC
 
Faculty:
Paul Forsberg, PharmD, MHA, BCOP
Director of Pharmacy
Minnesota Oncology
St. Paul, Minnesota
 
Latha Radhakrishnan, PharmD, BCOP
Clinical Oncology Pharmacist
The University of Illinois Hospital and Health Sciences System
Clinical Assistant Professor
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois
 
Paul Forsberg, PharmD, MHA, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Epizyme
Speakers Bureau: AstraZeneca
 
Latha Radhakrishnan, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Taiho, Novartis, Exelixis
Speakers Bureau: BMS, AstraZeneca, Taiho, Exelixis
 
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.
Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-22-363-H01-P. The activity is available for CE credit through July 29, 2023.
 
This activity is supported by independent medical education grants from Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals, Inc., and Sanofi Genzyme.
 https://www.pharmacytimes.org/courses/continuing-the-conversation-optimizing-frontline-immunotherapy-outcomes-in-nsclc-and-managed-care-considerations
Learn more about your ad choices. Visit megaphone.fm/adchoices

4 Can’t Miss Trends about Digital Engagement with Ritesh Patel | DarshanTalks

4 Can't Miss Trends about Digital Engagement! Coming up on Friday's livestream of the DarshanTalks Podcast with host Darshan Kulkarni and guest Ritesh Patel, originally streamed on July 15th, 2022. 
Learn more about your ad choices. Visit megaphone.fm/adchoices